-
Innovation Ranking
NewInnovation Ranking – COSCO Shipping Ports Ltd
COSCO Shipping Ports Ltd (COSCO Shipping Ports) manages and operates the terminals business. The company's services include container handling, transportation and logistics, storage and stevedoring, container reporting, and treasury services. COSCO Shipping Ports also offers terminal, cargo inspection, and management of transshipment services. It operates overseas and domestic ports located at Seattle, Zeebrugge, Euromax, Antwerp, Vado Reefer, and CSP Chancay terminal. COSCO Shipping Ports' other port terminals include Kumport, Piraeus, Suez Canal, Abu Dhabi, Busan, Ningbo, Quanzhou, Jinjiang, and Xiamen....
-
Innovation Ranking
NewInnovation Ranking – Qingdao Port International Ltd
Qingdao Port International Ltd (Qingdao Port), a subsidiary of COSCO Shipping Ports Ltd, is a provider of port and related services. The company offers port operations, container handling, metal ore and coal handling, liquid bulk handling, handling of general cargo and extended services. It also offers logistics and port value-added services, port ancillary services and financial services. The company operates Dagang Port Area, Qianwan Port Area, Huangdao Oil Port Area and Dongjiakou Port Area. Qingdao Port is headquartered in Shangdong,...
-
Analyst Opinions
Port Construction Project Insights and Analytics (Q1 2024)
Port Construction Projects Market Overview GlobalData is currently tracking a pipeline of port projects with a total value of $497 billion. South-East Asia accounts for the highest share of construction projects. Major markets in the region are investing substantially in port facilities to maximize trade opportunities with their trading partners and support high growth in trade volumes. The port construction projects market research report will offer a detailed analysis of Port construction projects globally. The report also provides details of...
-
Product Insights
Richards Bay Port Solar PV Park, South Africa
Richards Bay Port Solar PV Park is proposed to be developed in KwaZulu-Natal, South Africa. Empower your strategies with our Richards Bay Port Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PORT-6 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PORT-6 in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PORT-6 in Ovarian Cancer Drug Details: PORT-6 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PORT-6 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PORT-6 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PORT-6 in Colorectal Cancer Drug Details: PORT-6 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PORT-6 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PORT-6 in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PORT-6 in Endometrial Cancer Drug Details: PORT-6 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PORT-6 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PORT-6 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PORT-6 in Solid Tumor Drug Details: PORT-6 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PORT-6 in Head And Neck Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PORT-6 in Head And Neck Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PORT-6 in Head And Neck Cancer Drug Details: PORT-6 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PORT-6 in Metastatic Renal Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PORT-6 in Metastatic Renal Cell Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PORT-6 in Metastatic Renal Cell Carcinoma Drug Details: PORT-6 is...